Today, December 19, in Tokyo, within the framework of the "Central Asia + Japan" business forum, Ravshanbek Sabirov, head of the National Investment Agency under the President of the Kyrgyz Republic, met with Nomibitsu Akai, head of JFR Co. Ltd., to discuss cooperation in biotechnology. They explored the possibilities of producing probiotics in Kyrgyzstan to improve the health of people and animals, with a focus on applying Japanese quality standards and JFR Co. Ltd. technologies. The parties also discussed the prospects of introducing modern biotechnological solutions in Kyrgyzstan's agro-industrial sector to enhance the efficiency and sustainability of agricultural production. As a result of the meeting, the parties expressed mutual interest in further developing cooperation in biotechnology and formulating potential joint projects.
Navigation
All portal sections
$4.1B
Investments
180+
Projects
About the National Agency
Choose a section to go to
Live
19 December 2025 at 05:501 min read2
Future of Cooperation with Japanese Biotech Company JFR Co. Ltd. Discussed in Tokyo
Today, December 19, in Tokyo, within the framework of the "Central Asia + Japan" business forum, Ravshanbek Sabirov, head of the National Investment Agency under the President of the Kyrgyz Republic,










